Pinebridge Investments L.P. Buys 4,374 Shares of Amedisys, Inc. (NASDAQ:AMED)

Pinebridge Investments L.P. grew its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 40.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,118 shares of the health services provider's stock after purchasing an additional 4,374 shares during the period. Pinebridge Investments L.P.'s holdings in Amedisys were worth $1,373,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Barclays PLC increased its stake in Amedisys by 49.5% in the third quarter. Barclays PLC now owns 15,529 shares of the health services provider's stock valued at $1,500,000 after acquiring an additional 5,142 shares during the period. Oddo BHF Asset Management Sas bought a new position in shares of Amedisys in the third quarter worth about $7,238,000. Versant Capital Management Inc lifted its holdings in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after buying an additional 183 shares in the last quarter. HBW Advisory Services LLC acquired a new position in shares of Amedisys during the fourth quarter valued at $38,000. Finally, Oak Thistle LLC lifted its position in Amedisys by 97.6% during the 4th quarter. Oak Thistle LLC now owns 6,964 shares of the health services provider's stock valued at $632,000 after purchasing an additional 3,440 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Trading Up 0.8 %

AMED traded up $0.80 during mid-day trading on Friday, hitting $96.00. The stock had a trading volume of 1,114,163 shares, compared to its average volume of 413,398. The stock's fifty day simple moving average is $92.58 and its 200-day simple moving average is $91.74. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of 38.10, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping the consensus estimate of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $594.78 million for the quarter, compared to the consensus estimate of $597.43 million. During the same quarter last year, the business posted $1.03 EPS. The firm's revenue was up 4.1% compared to the same quarter last year. As a group, research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AMED has been the topic of a number of recent research reports. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Stephens restated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Amedisys presently has a consensus rating of "Hold" and an average price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.